++
++
Relatively common in pregnancy
Overt thyroid disease, both hypothyroidism and hyperthyroidism, are associated with adverse pregnancy outcomes
Women should be screened with thyroid function tests when
Overt hypothyroidism
Defined by an elevated serum TSH level with a depressed free thyroxine (FT4) level
The most common etiology is Hashimoto (autoimmune) thyroiditis
During pregnancy, several factors occur that affect maternal thyroid hormones
Rising estrogen levels increase thyroxine binding globulin (TBG) serum concentrations, reducing FT4 levels
Placental deiodinase promotes the turnover of T4
Supplemental iron and prenatal multivitamins containing iron can bind to oral T4 and reduce its intestinal absorption
Subclinical hypothyroidism
Defined as an increased serum TSH and a normal FT4 level
Early observational studies suggest that cognitive function is impaired in offspring of women with untreated subclinical hypothyroidism
Although some studies have found associations with untoward pregnancy outcomes such as miscarriage, preterm birth, and preeclampsia, others have failed to confirm these findings
There is currently no evidence that identification and treatment of subclinical hypothyroidism will prevent any of these outcomes
Overt hyperthyroidism
Transient autoimmune thyroiditis can occur in the postpartum period and is evident within the first year after delivery
++
++
++
Overt hypothyroidism
For women who need levothyroxine, increase the dosages by approximately 20–30% as soon as pregnancy is confirmed because fetal CNS development partially depends on maternal T4
Full replacement doses of 1.6 mcg/kg/day (about 100–150 mcg daily) should be given immediately to pregnant women with overt hypothyroidism or myxedema
By mid-pregnancy, women require an average of 47% increase in their levothyroxine dosage
Thyroid function tests can be ...